Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: A case report

Guido Poggi; Pietro Quaretti; Claudio Minoia; Ilaria Palumbo; Laura Villani; Alessio Amatu; Cristina Teragni; Mario Scelsi; Federico Zappoli; Giovanni Bernardo

Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: A case report

Guido Poggi, Pietro Quaretti, Claudio Minoia, Ilaria Palumbo, Laura Villani, Alessio Amatu, Cristina Teragni, Mario Scelsi, Federico Zappoli, Giovanni Bernardo

Research output: Contribution to journal › Article › peer-review

Abstract

Intmhepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable . disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.

Original language	English
Pages (from-to)	2987-2990
Number of pages	4
Journal	Anticancer Research
Volume	28
Issue number	5 B
Publication status	Published - Sep 2008

Keywords

Intrahepatic cholangiocarcinoma
Microspheres
Oxaliplatin
TACE

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

Fingerprint Dive into the research topics of 'Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: A case report'. Together they form a unique fingerprint.

Cite this

Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma : A case report. / Poggi, Guido; Quaretti, Pietro; Minoia, Claudio; Palumbo, Ilaria; Villani, Laura; Amatu, Alessio; Teragni, Cristina; Scelsi, Mario; Zappoli, Federico; Bernardo, Giovanni.

In: Anticancer Research, Vol. 28, No. 5 B, 09.2008, p. 2987-2990.

Research output: Contribution to journal › Article › peer-review

@article{837fc929515040fa9d6642df7a9e20fc,

title = "Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: A case report",

abstract = "Intmhepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable . disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.",

keywords = "Intrahepatic cholangiocarcinoma, Microspheres, Oxaliplatin, TACE",

author = "Guido Poggi and Pietro Quaretti and Claudio Minoia and Ilaria Palumbo and Laura Villani and Alessio Amatu and Cristina Teragni and Mario Scelsi and Federico Zappoli and Giovanni Bernardo",

year = "2008",

month = sep,

language = "English",

volume = "28",

pages = "2987--2990",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "5 B",

}

TY - JOUR

T1 - Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma

T2 - A case report

AU - Poggi, Guido

AU - Quaretti, Pietro

AU - Minoia, Claudio

AU - Palumbo, Ilaria

AU - Villani, Laura

AU - Amatu, Alessio

AU - Teragni, Cristina

AU - Scelsi, Mario

AU - Zappoli, Federico

AU - Bernardo, Giovanni

PY - 2008/9

Y1 - 2008/9

N2 - Intmhepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable . disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.

AB - Intmhepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable . disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.

KW - Intrahepatic cholangiocarcinoma

KW - Microspheres

KW - Oxaliplatin

KW - TACE

UR - http://www.scopus.com/inward/record.url?scp=55749116354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55749116354&partnerID=8YFLogxK

M3 - Article

C2 - 19031944

AN - SCOPUS:55749116354

VL - 28

SP - 2987

EP - 2990

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 B

ER -